These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 31031086

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
    Xie J, Lv J, Wang W, Li G, Liu Z, Chen H, Xu F, Sun J, Ouyang Y, Zhang X, Yang M, Shi M, Zhang W, Ren H, Kiryluk K, Zhang H, Chen N.
    Am J Kidney Dis; 2018 Sep; 72(3):371-380. PubMed ID: 29555434
    [Abstract] [Full Text] [Related]

  • 3. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
    Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Tsuchimoto A, Noguchi H, Hirakata H, Tsuruya K, Kitazono T.
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
    [Abstract] [Full Text] [Related]

  • 4. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, Li J, Xie D, Sun J, Zha Y, Li Y, Tian J, Liu Y, Hou FF.
    Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
    [Abstract] [Full Text] [Related]

  • 5. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L, Cai K, Wang K, Luo Q.
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.
    Barbour SJ, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Katafuchi R, Er L, Espino-Hernandez G, Kim SJ, Reich HN, Feehally J, Cattran DC, International IgA Nephropathy Network.
    JAMA Intern Med; 2019 Jul 01; 179(7):942-952. PubMed ID: 30980653
    [Abstract] [Full Text] [Related]

  • 8. Microangiopathic Lesions in IgA Nephropathy: A Cohort Study.
    Cai Q, Shi S, Wang S, Ren Y, Hou W, Liu L, Lv J, Haas M, Zhang H.
    Am J Kidney Dis; 2019 Nov 01; 74(5):629-639. PubMed ID: 31103332
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A Validation Study Comparing Risk Prediction Models of IgA Nephropathy.
    Ouyang Y, Zhao Z, Li G, Luo H, Xu F, Shao L, Chen Z, Yu S, Jin Y, Xu J, Shi M, Hussain HMJ, Du W, Fang Z, Pan X, Wang W, Xie J, Chen N.
    Front Immunol; 2021 Nov 01; 12():753901. PubMed ID: 34721428
    [Abstract] [Full Text] [Related]

  • 12. Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study.
    Zhu B, Liu WH, Lin Y, Li Q, Yu DR, Jiang F, Tang XL, Du YY, Yin JZ, Li XF, Zhong YZ, Wang WR, Sun Y, Zhang MJ, Gao YC, Yuan CY, Zhu CF, Cheng XX.
    Am J Nephrol; 2022 Nov 01; 53(6):455-469. PubMed ID: 35576899
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study.
    Liu S, Lu Z, Fu Z, Li H, Gui C, Deng Y.
    Kidney Blood Press Res; 2023 Nov 01; 48(1):186-193. PubMed ID: 37062274
    [Abstract] [Full Text] [Related]

  • 14. Arteriolar C4d in IgA Nephropathy: A Cohort Study.
    Faria B, Canão P, Cai Q, Henriques C, Matos AC, Poppelaars F, Gaya da Costa M, Daha MR, Silva R, Pestana M, Seelen MA.
    Am J Kidney Dis; 2020 Nov 01; 76(5):669-678. PubMed ID: 32439421
    [Abstract] [Full Text] [Related]

  • 15. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
    Wang S, Dong L, Pei G, Jiang Z, Qin A, Tan J, Tang Y, Qin W.
    Front Immunol; 2021 Nov 01; 12():700224. PubMed ID: 34456912
    [Abstract] [Full Text] [Related]

  • 16. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
    Yu GZ, Guo L, Dong JF, Shi SF, Liu LJ, Wang JW, Sui GL, Zhou XJ, Xing Y, Li HX, Lv JC, Zhang H.
    Am J Kidney Dis; 2020 Jul 01; 76(1):90-99. PubMed ID: 32197881
    [Abstract] [Full Text] [Related]

  • 17. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.
    Jiang Z, Tan J, Wang S, Dong L, Han X, Tang Y, Qin W.
    Int J Med Sci; 2021 Jul 01; 18(13):2964-2970. PubMed ID: 34220324
    [Abstract] [Full Text] [Related]

  • 18. Identification and external validation of IgA nephropathy patients benefiting from immunosuppression therapy.
    Chen T, Xia E, Chen T, Zeng C, Liang S, Xu F, Qin Y, Li X, Zhang Y, Liang D, Xie G, Liu Z.
    EBioMedicine; 2020 Feb 01; 52():102657. PubMed ID: 32062356
    [Abstract] [Full Text] [Related]

  • 19. Sex disparities in IgA nephropathy: a retrospective study in Chinese patients.
    Wen D, Tang Y, Tan L, Tan J, Chen D, Zhang Y, Qin W.
    Int Urol Nephrol; 2021 Feb 01; 53(2):315-323. PubMed ID: 32944891
    [Abstract] [Full Text] [Related]

  • 20. Prediction of ESRD in IgA Nephropathy Patients from an Asian Cohort: A Random Forest Model.
    Liu Y, Zhang Y, Liu D, Tan X, Tang X, Zhang F, Xia M, Chen G, He L, Zhou L, Zhu X, Liu H.
    Kidney Blood Press Res; 2018 Feb 01; 43(6):1852-1864. PubMed ID: 30537719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.